Lutz Lingnau, Director at NEKTAR THERAPEUTICS (NKTR), sold 7,000 shares at $20.05 ($140K) on 2017-04-07, disclosed to the SEC on 2017-04-11.
Open-market sale of $140k NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2018-09-21 | $513K | — | Filing → |
| NKTR | SELL | 2018-04-09 | $3.1M | — | Filing → |
| NKTR | SELL | 2017-09-25 | $110K | — | Filing → |